Placenta Accreta Spectrum Management: Uterine Preservation Using JSICA Technique - Retrospective Cross-Sectional Study

June 5, 2023 updated by: Amanda Rumondang, Dr Cipto Mangunkusumo General Hospital
The goal of this study is to present the Jakarta Surgical Uterine Conservation (JSICA) technique and its perioperative outcomes in Placenta Accreta Spectrum patients. Participants are all patients undergoing standard hysterectomy or the Jakarta Surgical Uterine Conservation (JSICA) technique. Researchers will compare both groups to see if there are any differences in the perioperative outcomes.

Study Overview

Detailed Description

This study uses data from Cipto Mangunkusumo General Hospital's Placenta Accreta Case Register. This register includes all patients with a confirmed placenta accreta spectrum diagnosis. Data collected includes demographic characteristics, risk factors, surgery characteristics, and perioperative outcomes. In this study, researchers would like to evaluate the perioperative outcomes of the JSICA technique in comparison to a standard hysterectomy.

Study Type

Interventional

Enrollment (Actual)

323

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • DKI Jakarta
      • Jakarta Pusat, DKI Jakarta, Indonesia, 10430
        • Maternal Fetal Medicine Division, Obstetric Gynecology Department Cipto Mangunkusumo General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria for JSICA:

  1. Focal accreta invasion ( < 50% anterior wall)
  2. Anterior invasion
  3. No parametrial or bladder invasion
  4. Residual tissue or healthy myometrium min 3 cm above the OUI or cervix
  5. Good uterine contraction post-repair (with or without compression sutures)
  6. Hemodynamically stable

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Jakarta Surgical Uterine Conservation (JSICA) technique
Cipto Mangunkusumo General Hospital's novel uterine preservation technique based on standard procedure
a. Identifying the placenta accrete site; b. Meticulous dissection to create a bladder flap; c. Incision 1 cm above the placenta accrete; d. Fetal delivery; e. Bottom incision to resect the placenta; f. Placental delivery; g. Uterus without placenta; h. The resection area is approximated using interrupted horizontal mattress suture; i. The continuous suture used to close all incision areas; j. Evaluation of uterine contraction
Active Comparator: Standard Hysterectomy
Surgery to remove the uterus
The main types of hysterectomy are abdominal, vaginal, and laparoscopic hysterectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative bleeding
Time Frame: Perioperative
Intraoperative bleeding in this study was measured by the amount of blood loss (cc) and classified into < 1.000 cc, 1.000-1.500 cc, and > 1.500 cc. .
Perioperative
Operation duration
Time Frame: Perioperative
The operation duration was the time interval from skin incision to closure (hours) and classified into < 3 hours and > 3 hours.
Perioperative
Number of Patients Admitted to ICU
Time Frame: 24 hours
ICU admission was identified by the documentation of number of patients' admission to the ICU
24 hours
Rate of Intraoperative complications
Time Frame: Intraoperative
Rate of intraoperative complications were identified by the documentation of injury to adjacent structures (bladder or ureter) or a need for transfusion.
Intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative Bleeding in JSICA compared to hysterectomy
Time Frame: Perioperative
Intraoperative bleeding in this study was measured by the amount of blood loss (cc) and classified into < 1.000 cc, 1.000-1.500 cc, and > 1.500 cc in comparison of JSICA to hysterectomy
Perioperative
Operation duration in JSICA compared to hysterectomy
Time Frame: Perioperative
The operation duration was the time interval from skin incision to closure (hours) and classified into < 3 hours and > 3 hours in comparison of JSICA to hysterectomy
Perioperative
Number of Patients Admitted to ICU in JSICA compared to hysterectomy
Time Frame: 24 hours
ICU admission was identified by the documentation of number of patients' admission to the ICU in comparison of JSICA to hysterectomy
24 hours
Rate of Intraoperative complications in JSICA compared to hysterectomy
Time Frame: Perioperative
Rate of intraoperative complications were identified by the documentation of injury to adjacent structures (bladder or ureter) or a need for transfusion in comparison of JSICA to hysterectomy
Perioperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

February 28, 2022

Study Registration Dates

First Submitted

February 27, 2023

First Submitted That Met QC Criteria

May 20, 2023

First Posted (Actual)

May 23, 2023

Study Record Updates

Last Update Posted (Actual)

June 7, 2023

Last Update Submitted That Met QC Criteria

June 5, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Placenta Accreta

Clinical Trials on Jakarta Surgical Uterine Conservation (JSICA) Technique

Subscribe